Andrew Komjathy Astria Therapeutics, Inc. (ATXS) insider trading activity

ATXS Quotes by TradingView

Andrew Komjathy is Chief Commercial Officer of Astria Therapeutics, Inc.. Currently has a direct ownership of 100 shares of ATXS, which is worth approximately $942. The most recent transaction as insider was on Nov 19, 2021, when has been sold 100 shares (Common Stock) at a price of $6.7 per share, resulting in proceeds of $670. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 100
0% 3M change
0% 12M change
Total Value Held $942

Andrew Komjathy Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 19 2021
BUY
Open market or private purchase
$670 $6.7 p/Share
100 Added 50.0%
100 Common Stock
AK

Andrew Komjathy

Chief Commercial Officer
Boston, MA

Track Institutional and Insider Activities on ATXS

Follow Astria Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATXS shares.

Notify only if

Insider Trading

Get notified when an Astria Therapeutics, Inc. insider buys or sells ATXS shares.

Notify only if

News

Receive news related to Astria Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ATXS